GKB Ophthalmics Ltd
Incorporated in 1981, GKB Ophthalmics Ltd is in the business of manufacture and sale of ophthalmic lenses made up of Glass and Plastic
- Market Cap ₹ 38.8 Cr.
- Current Price ₹ 77.0
- High / Low ₹ 132 / 59.0
- Stock P/E
- Book Value ₹ 35.1
- Dividend Yield 0.00 %
- ROCE -11.8 %
- ROE -29.5 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.08% over past five years.
- Company has a low return on equity of -16.6% over last 3 years.
- Contingent liabilities of Rs.17.9 Cr.
- Promoter holding has decreased over last 3 years: -8.67%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
31.38 | 29.85 | 31.17 | 40.65 | 37.43 | 30.47 | 25.56 | 21.34 | 27.05 | 27.73 | 31.18 | 32.75 | 32.91 | |
25.58 | 30.63 | 33.61 | 41.05 | 38.41 | 31.52 | 26.29 | 21.63 | 27.44 | 28.82 | 32.46 | 36.22 | 36.80 | |
Operating Profit | 5.80 | -0.78 | -2.44 | -0.40 | -0.98 | -1.05 | -0.73 | -0.29 | -0.39 | -1.09 | -1.28 | -3.47 | -3.89 |
OPM % | 18.48% | -2.61% | -7.83% | -0.98% | -2.62% | -3.45% | -2.86% | -1.36% | -1.44% | -3.93% | -4.11% | -10.60% | -11.82% |
1.18 | 1.72 | 23.08 | 4.11 | 1.05 | 2.62 | 1.38 | 2.33 | 1.91 | 2.09 | 2.08 | 1.97 | 1.95 | |
Interest | 2.86 | 2.49 | 1.61 | 1.26 | 1.23 | 1.39 | 1.35 | 1.34 | 1.34 | 1.50 | 1.59 | 1.89 | 2.16 |
Depreciation | 1.18 | 1.48 | 1.42 | 1.34 | 1.58 | 3.43 | 3.47 | 2.99 | 2.49 | 2.54 | 2.59 | 2.64 | 2.66 |
Profit before tax | 2.94 | -3.03 | 17.61 | 1.11 | -2.74 | -3.25 | -4.17 | -2.29 | -2.31 | -3.04 | -3.38 | -6.03 | -6.76 |
Tax % | 71.77% | -25.41% | 22.43% | 31.53% | -6.20% | -14.77% | 0.00% | -7.86% | 0.00% | -5.26% | 1.18% | 1.16% | |
0.83 | -2.26 | 13.66 | 0.76 | -2.58 | -2.78 | -4.17 | -2.11 | -2.31 | -2.88 | -3.42 | -6.11 | -6.84 | |
EPS in Rs | 2.00 | -5.44 | 32.89 | 1.83 | -6.21 | -5.99 | -8.27 | -4.19 | -4.58 | -5.71 | -6.78 | -12.12 | -13.58 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 1% |
5 Years: | 5% |
3 Years: | 7% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -12% |
3 Years: | % |
TTM: | -40% |
Stock Price CAGR | |
---|---|
10 Years: | 1% |
5 Years: | 7% |
3 Years: | -5% |
1 Year: | -29% |
Return on Equity | |
---|---|
10 Years: | -11% |
5 Years: | -11% |
3 Years: | -17% |
Last Year: | -30% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.64 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 |
Reserves | 13.84 | 11.14 | 24.80 | 25.44 | 22.78 | 30.03 | 30.21 | 27.73 | 25.36 | 22.48 | 18.95 | 12.63 |
12.51 | 8.62 | 7.22 | 7.19 | 9.93 | 10.05 | 10.04 | 11.97 | 11.75 | 11.22 | 11.08 | 18.09 | |
20.67 | 24.79 | 11.36 | 10.22 | 8.57 | 10.45 | 11.40 | 12.13 | 11.74 | 10.41 | 13.32 | 13.72 | |
Total Liabilities | 51.17 | 48.70 | 47.53 | 47.00 | 45.43 | 55.17 | 56.69 | 56.87 | 53.89 | 49.15 | 48.39 | 49.48 |
13.61 | 11.72 | 12.49 | 16.43 | 16.98 | 24.29 | 24.83 | 22.28 | 21.27 | 17.28 | 15.89 | 14.44 | |
CWIP | 0.57 | 0.57 | 0.57 | 0.57 | 0.24 | 0.00 | 0.00 | 1.23 | 3.29 | 3.82 | 3.78 | 3.78 |
Investments | 5.53 | 5.53 | 10.45 | 3.77 | 0.66 | 0.32 | 3.21 | 12.22 | 11.90 | 11.90 | 11.90 | 11.90 |
31.46 | 30.88 | 24.02 | 26.23 | 27.55 | 30.56 | 28.65 | 21.14 | 17.43 | 16.15 | 16.82 | 19.36 | |
Total Assets | 51.17 | 48.70 | 47.53 | 47.00 | 45.43 | 55.17 | 56.69 | 56.87 | 53.89 | 49.15 | 48.39 | 49.48 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
5.47 | 5.87 | -11.90 | -4.20 | -3.71 | 5.31 | 6.13 | 2.11 | 2.33 | -1.14 | 1.36 | -5.04 | |
-0.65 | 0.13 | 14.74 | 5.50 | 2.28 | -8.63 | -5.68 | -11.52 | -0.83 | 2.40 | 0.37 | -0.16 | |
-4.82 | -6.00 | -2.81 | -1.29 | 1.41 | 9.21 | 3.31 | 0.61 | -1.50 | -2.03 | -1.74 | 5.12 | |
Net Cash Flow | 0.00 | 0.00 | 0.02 | 0.00 | -0.02 | 5.88 | 3.76 | -8.80 | 0.00 | -0.78 | 0.00 | -0.07 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 175.87 | 176.57 | 92.63 | 66.00 | 101.81 | 129.49 | 148.08 | 127.25 | 80.96 | 64.23 | 80.30 | 83.48 |
Inventory Days | 409.77 | 350.98 | 285.25 | 283.50 | 264.10 | 154.90 | 133.50 | 256.82 | 141.86 | 161.81 | 102.38 | 120.22 |
Days Payable | 232.25 | 362.47 | 119.63 | 106.91 | 84.89 | 171.32 | 222.98 | 251.31 | 158.86 | 139.11 | 157.83 | 137.81 |
Cash Conversion Cycle | 353.40 | 165.08 | 258.24 | 242.59 | 281.01 | 113.07 | 58.61 | 132.77 | 63.96 | 86.93 | 24.86 | 65.88 |
Working Capital Days | 14.66 | -21.15 | 69.79 | 80.72 | 94.59 | -7.67 | -56.12 | -86.38 | -85.68 | -60.02 | -85.22 | -70.10 |
ROCE % | 17.31% | -3.86% | -6.26% | -0.77% | -4.13% | -8.09% | -6.29% | 0.13% | -2.14% | -3.96% | -4.96% | -11.80% |
Documents
Announcements
- GKB Ophthalmics Limited - Unaudited Standalone & Consolidated Financial Results - June 30, 2025 1d
-
Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On August 14, 2025
1d - Q1 FY26 unaudited results show loss; ongoing labor dispute case under appeal by company.
-
Board Meeting Intimation for Board Meeting For Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2025.
31 Jul - Board meeting on Aug 14, 2025 to approve Q1 unaudited results; trading window reopening details.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 Jul - Copies of newspaper cuttings of the Notice published in The Times of India (Goa Edition) dated July 29, 2025 and on Pudhari (Mumbai) dated July …
- Reg. 34 (1) Annual Report. 29 Jul
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Profile:[1]
a) Single Vision: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck 1.56 DayNite, 1.56 DayNite FAST CHANGE, 1.50 Q-SHADE +, 1.50 SunSensor
b) Bifocal: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
c) Progressive: 1.498 CR-39, 1.50 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
d) Aspheric: 1.498 CR-39